Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric O'Neill

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Gut|January 9, 2025
Induction of macrophage efferocytosis in pancreatic cancer via PI3Kγ inhibition and radiotherapy promotes tumour controlShannon Nicole Russell, Constantinos Demetriou, Giampiero Valenzano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2013
Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathwayLana McClements, Anita Yakkundi, Angelos Papaspyropoulos, et al.
Science Advances|February 14, 2025
ATR-hippo drives force signaling to nuclear F-actin and links mechanotransduction to neurological disordersMaria Chatzifrangkeskou, Tess Stanly, Delia Koennig, et al.
Cancer Research|August 3, 2017
Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic CancerZenobia D'Costa, Keaton Jones, Abul Azad, et al.
The EMBO Journal|September 17, 2021
RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axisMaria Laura Tognoli, Nikola Vlahov, Sander Steenbeek, et al.
BMC Cancer|February 6, 2019
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)Victoria Y Strauss, Rachel Shaw, Pradeep S Virdee, et al.
The Journal of Clinical Investigation|August 19, 2014
Menin determines K-RAS proliferative outputs in endocrine cellsChester E Chamberlain, David W Scheel, Kathleen McGlynn, et al.
Plos One|June 16, 2012
RNA folding and catalysis mediated by iron (II)Shreyas S Athavale, Anton S Petrov, Chiaolong Hsiao, et al.
International Journal of Epidemiology|January 22, 2022
Circulating proteins and risk of pancreatic cancer: a case-subcohort study among Chinese adultsChristiana Kartsonaki, Yuanjie Pang, Iona Millwood, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 28, 2016
ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancerJames M Wilson, Emmanouil Fokas, Susan J Dutton, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Gut|January 9, 2025
Induction of macrophage efferocytosis in pancreatic cancer via PI3Kγ inhibition and radiotherapy promotes tumour controlShannon Nicole Russell, Constantinos Demetriou, Giampiero Valenzano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2013
Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathwayLana McClements, Anita Yakkundi, Angelos Papaspyropoulos, et al.
Science Advances|February 14, 2025
ATR-hippo drives force signaling to nuclear F-actin and links mechanotransduction to neurological disordersMaria Chatzifrangkeskou, Tess Stanly, Delia Koennig, et al.
Cancer Research|August 3, 2017
Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic CancerZenobia D'Costa, Keaton Jones, Abul Azad, et al.
The EMBO Journal|September 17, 2021
RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axisMaria Laura Tognoli, Nikola Vlahov, Sander Steenbeek, et al.
BMC Cancer|February 6, 2019
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)Victoria Y Strauss, Rachel Shaw, Pradeep S Virdee, et al.
The Journal of Clinical Investigation|August 19, 2014
Menin determines K-RAS proliferative outputs in endocrine cellsChester E Chamberlain, David W Scheel, Kathleen McGlynn, et al.
Plos One|June 16, 2012
RNA folding and catalysis mediated by iron (II)Shreyas S Athavale, Anton S Petrov, Chiaolong Hsiao, et al.
International Journal of Epidemiology|January 22, 2022
Circulating proteins and risk of pancreatic cancer: a case-subcohort study among Chinese adultsChristiana Kartsonaki, Yuanjie Pang, Iona Millwood, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 28, 2016
ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancerJames M Wilson, Emmanouil Fokas, Susan J Dutton, et al.
Pageof 8